A systematic review of 29,941 patients shows that preoperative MRI findings significantly improve risk stratification for men with prostate cancer undergoing radical prostatectomy.

Medically reviewed by Jamin Brahmbhatt, MD Metastatic castration-resistant prostate cancer (mCRPC) is a type of advanced ...

New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in ...

Pre-treatment prostate MRI predicts recurrence and survival after surgery. Discover how imaging improves risk assessment.

Cribriform-positive prostate cancer outcomes needs to be further risk stratified to identify patients at high risk for metastasis.

Transdermal oestradiol patches are non-inferior to luteinising hormone-releasing hormone agonists for metastasis free survival in locally advanced prostate cancer, a study shows.

Northwestern Medicine scientists have discovered that a specific long non-coding RNA activates oncogenic signaling pathways in prostate cancer cells and drives tumor progression, underscoring its ...

Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all ...

Metformin raised the exercise-linked metabolite Lac-Phe in prostate cancer patients across disease stages and treatment ...